Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (10): 885-889    DOI: 10.19485/j.cnki.issn2096-5087.2023.10.012
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2011—2022年开化县肺癌发病和死亡趋势分析
项彩英, 汪德兵
开化县疾病预防控制中心慢病科,浙江 开化 324300
Trends in incidence and mortality of lung cancer in Kaihua County from 2011 to 2022
XIANG Caiying, WANG Debing
Department of Non-communicable Diseases Control and Prevention, Kaihua County Center for Diseases Control and Prevention, Kaihua, Zhejiang 324300, China
全文: PDF(764 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2011—2022年浙江省开化县肺癌发病和死亡趋势,为完善肺癌防治策略提供依据。方法 通过浙江省慢性病监测信息管理系统收集2011—2022年开化县肺癌发病和死亡资料,分析肺癌粗发病率、标化发病率、粗死亡率和标化死亡率;计算平均年度变化百分比(AAPC)分析肺癌发病率和死亡率变化趋势。结果 2011—2022年开化县肺癌粗发病率和标化发病率均呈上升趋势(AAPC=5.409%、2.957%,均P<0.05);年均粗发病率为75.17/10万,年均标化发病率为44.37/10万。男性肺癌年均粗发病率为100.16/10万,年均标化发病率为58.03/10万,高于女性的48.55/10万和30.61/10万(均P<0.05)。男性肺癌粗发病率呈上升趋势(AAPC=2.878%,P<0.05),标化发病率未见明显变化趋势(P>0.05);女性肺癌粗发病率和标化发病率均呈上升趋势(AAPC=11.596%、10.464%,均P<0.05)。肺癌粗发病率在45岁之后开始快速上升,在80~<85岁组达到峰值(32.11/10万)。2011—2022年开化县肺癌粗死亡率呈上升趋势,标化死亡率呈下降趋势(AAPC=1.554%、-2.491%,均P<0.05),年均粗死亡率为52.83/10万,年均标化死亡率为29.09/10万。男性肺癌年均粗死亡率为77.92/10万,年均标化死亡率为43.66/10万,均高于女性的26.10/10万和14.33/10万(均P<0.05)。男性肺癌粗死亡率呈上升趋势,标化死亡率呈下降趋势(AAPC=1.436%、-2.553%,均P<0.05);女性肺癌粗死亡率和标化死亡率未见明显变化趋势(均P>0.05)。肺癌粗死亡率在50岁之后开始快速上升,在80~<85岁组达到峰值(37.26/10万)。结论 2011—2022年开化县肺癌发病率和死亡率均呈上升趋势,其中女性发病率上升速度较快。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
项彩英
汪德兵
关键词 肺癌发病率死亡率    
AbstractObjective To investigate the trends in incidence and mortality of lung cancer in Kaihua County, Zhejiang Province from 2011 to 2022, so as to provide insights into improving lung cancer prevention and control strategy. Methods The incidence and mortality of lung cancer in Kaihua County from 2011 to 2022 were collected through Zhejiang Provincial Chronic Disease Surveillance Information Management System. The crude incidence, standardized incidence, crude mortality and standardized mortality of lung cancer were analyzed, and the trends in incidence and mortality of lung cancer were evaluated using average annual percent change (AAPC). Results The crude and standardized incidence of lung cancer appeared a tendency towards an increase (AAPC=5.409% and 2.957%, both P<0.05) from 2011 to 2022, with an average annual crude incidence of 75.17/105 and average annual standardized incidence of 44.37/105. Average annual crude incidence (100.16/105 vs. 48.55/105) and standardized incidence (58.03/105 vs. 30.61/105) of lung cancer was higher in males than in females (both P<0.05). The crude incidence of lung cancer in males appeared a tendency towards an increase (AAPC=2.878%, P<0.05), with no significant changing patterns seen in standardized incidence (P>0.05). The crude and standardized incidence of lung cancer in females showed a tendency towards an increase (AAPC=11.596% and 10.464%, both P<0.05). The crude incidence of lung cancer increased rapidly among residents at ages of 45 years and older, and peaked among residents at ages of 80 to 84 years (32.11/105). The crude and standardized mortality of lung cancer appeared a tendency towards a rise and decline (AAPC=1.554% and -2.491%, both P<0.05) from 2011 to 2022, with an average annual crude and standardized mortality of 52.83/105 and 29.09/105. Average annual crude mortality (77.92/105 vs. 26.10/105) and standardized mortality (43.66/105 vs. 14.33/105) of lung cancer was higher in males than in females (both P<0.05). The crude mortality of lung cancer in males appeared a tendency towards a rise, while the standardized mortality appeared a tendency towards a decline (AAPC=1.436% and -2.553%, both P<0.05). No significant changing patterns were seen in crude and standardized mortality of lung cancer in females (both P>0.05). The crude mortality of lung cancer increased rapidly among residents at ages of 50 years and older, and peaked among residents at ages of 80 to 84 years (37.26/105). Conclusion The incidence and mortality of lung cancer appeared a tendency towards an increase in Kaihua County from 2011 to 2022, and a rapid increase was seen in the incidence of lung cancer in females.
Key wordslung cancer    incidence    mortality
收稿日期: 2023-07-17      修回日期: 2023-09-06      出版日期: 2023-10-10
中图分类号:  R734.2  
通信作者: 汪德兵,E-mail:365362086@qq.com   
作者简介: 项彩英,本科,副主任技师,主要从事慢性病监测工作
引用本文:   
项彩英, 汪德兵. 2011—2022年开化县肺癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(10): 885-889.
XIANG Caiying, WANG Debing. Trends in incidence and mortality of lung cancer in Kaihua County from 2011 to 2022. Preventive Medicine, 2023, 35(10): 885-889.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.10.012      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I10/885
[1] 肖佳龙,郑莹.全球肺癌的流行及预防进展[J].中国癌症杂志,2020,30(10):721-725.
[2] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3] XIA C F,DONG X S,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[4] 李翔,高申.1990—2019年中国居民肺癌发病、患病和死亡趋势分析[J].中国慢性病预防与控制,2021,29(11):821-826.
[5] 郑荣寿,张思维,孙可欣,等.2016年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2023,45(3):212-220.
[6] 李金,黄文,陈奇峰.2014—2019年绍兴市肺癌发病趋势分析[J].预防医学,2021,33(9):889-892.
[7] 胡如英,展元元,王蒙,等.浙江省成人吸烟行为趋势研究[J].预防医学,2018,30(12):1189-1193,1198.
[8] GBD 2019 Respiratory Tract Cancers Collaborators.Global,regional,and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019:a systematic analysis for the Global Burden of Disease Study 2019BD 2019 Respiratory Tract Cancers Collaborators.Global,regional,and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Respir Med,2021,9(9):1030-1049.
[9] 王临池,周金意,韩仁强,等.江苏省2015年肺癌流行现况与2006—2015年变化趋势分析[J].中国肿瘤,2020,29(8):579-585.
[10] MENG Y,LIU X H,LU S Y,et al.A review on occurrence and risk of polycyclic aromatic hydrocarbons(PAHs)in lakes of China[J].Sci Total Environ,2019,651:2497-2506.
[11] 林秀琴,徐健,许树红,等.ADH、ALDH基因多态性与饮酒的交互作用对肺癌的影响研究[J].预防医学,2021,33(10):1022-1025,1029.
[12] SAMUELSSON L B,BOVBJERG D H,ROECKLEIN K A,et al.Sleep and circadian disruption and incident breast cancer risk:an evidence-based and theoretical review[J].Neurosci Biobehav Rev,2018,84:35-48.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 郑伟, 张世勇, 杨纶砥, 熊华利. 基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J]. 预防医学, 2023, 35(8): 665-668,681.
[3] 李玉荣, 汪芬娟, 王冬飞, 林君英, 蒋园园, 高媛媛, 赵芳芳. 2015—2020年萧山区恶性肿瘤发病趋势分析[J]. 预防医学, 2023, 35(8): 687-691.
[4] 王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典. 2011—2022年宁波市胃癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(7): 557-562.
[5] 安静, 李辉, 盛红斌, 蒋琦. 2012—2021年湖州市5岁以下儿童死亡监测资料分析[J]. 预防医学, 2023, 35(7): 628-631.
[6] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[7] 郑颖, 陈述, 钱棪梅, 唐晓翠, 李秀央. 2016—2022年金东区脑卒中发病趋势分析[J]. 预防医学, 2023, 35(7): 611-614.
[8] 王永, 应焱燕, 陈洁平, 崔军, 包凯芳, 李思萱, 朱银潮, 王思嘉, 徐典, 冯宏伟. 2002—2022年宁波市恶性肿瘤死亡趋势分析[J]. 预防医学, 2023, 35(6): 496-500,505.
[9] 初里楠, 董奕, 李竹, 张燕, 朱丹红. 2014—2021年西城区恶性肿瘤死亡及减寿分析[J]. 预防医学, 2023, 35(5): 410-414.
[10] 崔俊鹏, 陆艳, 黄春妍, 华钰洁, 王临池. 2007—2021年苏州市女性乳腺癌死亡与减寿分析[J]. 预防医学, 2023, 35(5): 380-383.
[11] 张瑞洁, 纪威, 韩丽媛, 张良. 2012—2021年宁波市脑卒中发病和死亡趋势分析[J]. 预防医学, 2023, 35(3): 224-228.
[12] 周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
[13] 赵信星, 陈洪恩, 董晓, 邹泉, 梁晓峰, 吴静, 王长义. 2010—2021年南山区脑卒中发病趋势[J]. 预防医学, 2023, 35(3): 200-204.
[14] 许树红, 单杏仁, 卢巧玲, 孟海滨, 余佳琦. 2012—2021年绍兴市生殖道沙眼衣原体感染流行病学特征[J]. 预防医学, 2023, 35(2): 148-151.
[15] 刘锐, 蔺茂文, 江鸿, 李舒超, 张凡, 孙春. 2008—2022年荆州市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J]. 预防医学, 2023, 35(10): 871-876.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed